Amneal Pharmaceuticals, Inc. AMRX International — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s international — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s international — net revenue?
- Amneal Pharmaceuticals, Inc. (AMRX) reported international — net revenue of $5.32M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s international — net revenue changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s international — net revenue increased by 331.0% year-over-year, from $1.23M to $5.32M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s international — net revenue?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s international — net revenue has grown at a 102.1% compound annual growth rate (CAGR), from $1.47M to $12.13M.
- What does international — net revenue mean?
- This metric represents the total gross sales generated from products sold outside of the company's primary domestic market, net of returns, allowances, and discounts. It serves as a key indicator of the company's geographic diversification and the success of its global commercial expansion strategy. Monitoring this revenue stream helps investors assess the company's ability to capture market share in international territories and mitigate reliance on domestic economic conditions.